Log in
Enquire now
‌

US Patent 8361465 Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents

Patent 8361465 was granted and assigned to Lpath on January, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Patent abstract

The present invention relates to use of anti-S1P antibodies in combination with chemotherapeutic agents for treatment and/or prevention of cancer, tumor growth, metastasis and/or growth of metastatic tumors.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8361465 Use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo